Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares fell 2.1% during mid-day trading on Wednesday . The stock traded as low as $1.87 and last traded at $1.90. 219,732 shares traded hands during trading, an increase of 227% from the average session volume of 67,097 shares. The stock had previously closed at $1.94.
Cardiol Therapeutics Stock Performance
The stock has a fifty day moving average price of $2.03 and a 200 day moving average price of $1.98.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Articles
- Five stocks we like better than Cardiol Therapeutics
- Insider Trades May Not Tell You What You Think
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- CD Calculator: Certificate of Deposit Calculator
- Introduction to Fibonacci Retracement Levels
- Best Stocks Under $5.00
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
